MD2-97089-78506
3 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 553 / MN
- Registered
- 2022-03-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Dose 1 — Moderna
-
2021-05-01
Dose 2 — Moderna
-
2021-12-28
Dose 3 — Moderna
-
2022-03-24
Registered in v-safe
-
2022-03-31
Survey response — 3 months, dose 3MedDRA: Fatigue, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Chronic severe daily hives since 1/10. Fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-04
-
2022-04-04
Call successfulCompleted over the phone
- 2022-06-28
- 2022-12-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Moderna | No |
| 2 | 2021-05-01 | Moderna | No |
| 3 | 2021-12-28 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 11 — 3 months, dose 3
Symptoms: Chronic severe daily hives since 1/10. Fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release